Products
Platform
Research
Market
Learn
IPO
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹1000 | - |
Expense Ratio | 2.4 | - |
NAV | ₹15.49 | - |
Fund Started | 27 Jun 2023 | - |
Fund Size | ₹383.96 Cr | - |
Exit Load | Exit load of 1%, if redeemed within 15 days. | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹1000
-
Expense Ratio
2.4
-
NAV
₹15.49
-
Fund Started
27 Jun 2023
-
Fund Size
₹383.96 Cr
-
Exit Load
Exit load of 1%, if redeemed within 15 days.
-
Returns
1 Year | -2.36% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
-2.36%
-
3 Year
-
-
5 Year
-
-
Holding Analysis
Equity | 97.45% | - |
Cash | -3.65% | - |
Equity
97.45%
-
Cash
-3.65%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Cipla Ltd. | 8.45% |
Sequent Scientific Ltd. | 8.26% |
Zydus Wellness Ltd. | 7.97% |
Aster DM Healthcare Ltd. | 7.89% |
Lupin Ltd. | 6.76% |
SMS Pharmaceuticals Ltd. | 6.53% |
Pfizer Ltd. | 6.51% |
Aurobindo Pharma Ltd. | 6.45% |
Anthem Biosciences Ltd. | 6.17% |
Adani Enterprises Ltd. | 6.14% |
-
Fund Manager
Name | Ankit A Pande | - |
Start Date | 07 Jul 2025 | - |
Name
Ankit A Pande
-
Start Date
07 Jul 2025
-
About Fund
Description | The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns. | - |
Launch Date | 27 Jun 2023 | - |
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
-
Launch Date
27 Jun 2023
-